>

KAMADA Stock Profile

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 40px;;'>KMD</div>

Performance

0 / 100

Odds of Distress

Analyze Filter   Check how we calculate scores
Equity ratings for KAMADA are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 27, 2019 and ending today February 25, 2020. Click here to learn more.

KAMADA Profile

Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. Kamada Ltd. was founded in 1990 and is headquartered in Rehovot, Israel. KAMADA operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. more on KAMADA
Legal NameKAMADA
CEOGil EfronView All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Profitability
Few selected profitability drivers of KAMADA representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Net Income
Operating Income
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
KAMADA (KMDA) is traded on Tel Aviv Stock Exchange in Israel and employs 408 people. The company currently falls under 'Small-Cap' category with current market capitalization of 907.31 M. KAMADA operates under Healthcare sector and is part of Biotechnology industry. The entity has 40.35 M outstanding shares. KAMADA LTD has accumulated about 66.83 M in cash with 25.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.61.
Check KAMADA Probability Of Bankruptcy

Ownership Allocation (%)

KAMADA Stock Price Odds Analysis

Odds Below 2150.0HorizonTargetOdds Above 2150.0
11.66%30 days 2,150 88.25%
Based on normal probability distribution, the odds of KAMADA to move above current price in 30 days from now is about 88.25 (This KAMADA probability density function shows the probability of KAMADA Stock to fall within a particular range of prices over 30 days) .

KAMADA Income Statement Over Time

Direct Expenses    Net Income    Revenues    

KAMADA Stock Against Markets

Did you try this?

Run Fundamentals Matrix Now

   

Fundamentals Matrix

View fundamentals matrix and analyze how accounts are interrelated and interconnected with each other
All  Next Launch Module

KAMADA Corporate Directors

Itzhak Krinsky Director
Tuvia Shoham Independent Director
Abraham Havron Independent Director
Please see Stocks Correlation. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.
Company logos by clearbit